Willingness to provide a hair sample for drug testing among electronic dance music party attendees

References

• Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51:253–263.
   PubMed Web of Science ®Google Scholar
• Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997;167:17–36.
   PubMedGoogle Scholar
• Pichini S, Solimini R, Berretta P, Pacifici R, Busardo FP. Acute intoxications and fatalities from illicit fentanyl and analogues: an update. Ther Drug Monit. 2018;40:38–51.
   PubMed Web of Science ®Google Scholar
• Presence of fentanyl in cocaine contributing to increase in drug overdose deaths [press release]. 2017.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. European Drug Report. 2017; Lisbon: 2017.
   Google Scholar
• U.S. Drug Enforcement Administration DCD. National Forensic Laboratory Information System: Year 2016 Annual Report. Springfield, VA; 2017.
   Google Scholar
• Drug Enforcement Administration. Emerging Threat Report: Mid-year. 2017:2017.
   Google Scholar
• Brunt TM, Nagy C, Bucheli A, et al. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Drug. Drug Test Analysis. 2017;9:188–198.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Salomone A, Vincenti M, Cleland CM. Detection of “bath salts” and other novel psychoactive substances in hair samples of ecstasy/MDMA/“Molly” users. Drug Alcohol Depend. 2016;161:200–205.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Salomone A, Gerace E, Di Corcia D, Vincenti M, Cleland CM. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene. Int J Drug Policy. 2017;48:91–98.
   PubMed Web of Science ®Google Scholar
• Wood DM, Stribley V, Dargan PI, Davies S, Holt DW, Ramsey J. Variability in the 3,4-methylenedioxymethamphetamine content of ‘ecstasy’ tablets in the UK. Emerg Med J. 2011;28:764–765.
   PubMed Web of Science ®Google Scholar
• Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ. Content of ecstasy in the Netherlands: 1993–2008. Addiction. 2009;104:2057–2066.
   PubMed Web of Science ®Google Scholar
• Caudevilla-Gálligo F, Ventura M, Indave Ruiz BI, Fornís I. Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010–2012). Hum Psychopharmacol Clin Exp. 2013;28:341–344.
   PubMed Web of Science ®Google Scholar
• Vidal Gine C, Ventura Vilamala M, Fornis Espinosa I, et al. Crystals and tablets in the Spanish ecstasy market 2000–2014: are they the same or different in terms of purity and adulteration? Forensic Sci Int. 2016;263:164–168.
   PubMed Web of Science ®Google Scholar
• Renfroe CL. MDMA on the street: Analysis Anonymous. J Psychoactive Drugs. 1986;18:363–369.
   PubMed Web of Science ®Google Scholar
• Murray RA, Doering PL, Boothby LA, et al. Putting an ecstasy test kit to the test: harm reduction or harm induction? Pharmacotherapy 2003;23:1238–1244.
   PubMed Web of Science ®Google Scholar
• Saleemi S, Pennybaker SJ, Wooldridge M, Johnson MW. Who is ‘Molly’? MDMA adulterants by product name and the impact of harm-reduction services at raves. J Psychopharmacol (Oxford, England). 2017;31:1056–1060.
   PubMed Web of Science ®Google Scholar
• Gine CV, Vilamala MV, Measham F, et al. The utility of drug checking services as monitoring tools and more: a response to Pirona et al. Int J Drug Policy. 2017;45:46–47.
   PubMed Web of Science ®Google Scholar
• Martins D, Barratt MJ, Pires CV, et al. The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal’s Boom Festival. Hum Psychopharmacol Clin Exp. 2017;32:e2608.
   Web of Science ®Google Scholar
• Fendrich M, Johnson TP, Wislar JS, Hubbell A, Spiehler V. The utility of drug testing in epidemiological research: results from a general population survey. Addiction. 2004;99:197–208.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Griffin-Tomas M, Ompad DC. Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug Alcohol Depend. 2015;152:24–31.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Acosta P, Ompad DC, Cleland CM. Self-reported ecstasy/MDMA/“molly” use in a sample of nightclub and dance festival attendees in New York City. Subst Use Misuse. 2017;52:82–91.
   PubMed Web of Science ®Google Scholar
• Miller BA, Byrnes HF, Branner AC, Voas R, Johnson MB. Assessment of club patrons' alcohol and drug use: the use of biological markers. Am J Prev Med. 2013;45:637–643.
   PubMed Web of Science ®Google Scholar
• Surratt HL, Kurtz SP, Buttram M, Levi-Minzi MA, Pagano ME, Cicero TJ. Heroin use onset among nonmedical prescription opioid users in the club scene. Drug Alcohol Depend. 2017;179:131–138.
   PubMed Web of Science ®Google Scholar
• Kelly BC, Parsons JT, Wells BE. Prevalence and predictors of club drug use among club-going young adults in New York City. J Urban Health. 2006;83:884–895.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Kawsar A, Ramsey J, Dargan PI, Wood DM. Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs. QJM 2013;106:1111–1117.
   PubMed Web of Science ®Google Scholar
• Mohr ALA, Friscia M, Yeakel JK, Logan BK. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees. Forensic Sci Int. 2018;282:168–178.
   PubMed Web of Science ®Google Scholar
• Miller P, Curtis A, Jenkinson R, Droste N, Bowe SJ, Pennay A. Drug use in Australian nightlife settings: estimation of prevalence and validity of self-report. Addiction 2015;110:1803–1810.
   PubMed Web of Science ®Google Scholar
• Miller BA, Furr-Holden D, Johnson MB, Holder H, Voas R, Keagy C. Biological markers of drug use in the club setting. J Stud Alcohol Drugs. 2009;70:261–268.
   PubMed Web of Science ®Google Scholar
• Johnson MB, Voas RA, Miller BA, Holder HD. Predicting drug use at electronic music dance events: self-reports and biological measurement. Eval Rev. 2009;33:211–225.
   PubMed Web of Science ®Google Scholar
• Jufer R, Walsh SL, Cone EJ, Sampson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. Anal Toxicol. 2006;30:458–462.
   PubMed Web of Science ®Google Scholar
• Smith-Kielland A, Skuterud B, Mørland J. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol. 1999;23:323–332.
   PubMed Web of Science ®Google Scholar
• Vindenes V, Yttredal B, Oiestad EL, et al. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. J Anal Toxicol. 2011;35:32–39.
   PubMed Web of Science ®Google Scholar
• Caplan YH, Goldberger BA. Alternative specimens for workplace drug Testing. J Anal Toxicol. 2001;25:396–399.
   PubMed Web of Science ®Google Scholar
• Kintz P, Salomone A, Vincenti M. Hair Analysis in Clinical and Forensic Toxicology. San Diego, CA: Academic Press; 2015.
   Google Scholar
• Fendrich M, Johnson TP, Wislar JS, Hubbell A. Drug test feasibility in a general population household survey. Drug Alcohol Depend. 2004;73:237–250.
   PubMed Web of Science ®Google Scholar
• Ford JL, Boch SJ, McCarthy DO. Feasibility of hair collection for cortisol measurement in population research on adolescent health. Nurs Res. 2016;65:249–255.
   PubMed Web of Science ®Google Scholar
• Colon HM, Robles RR, Sahai H. The validity of drug use responses in a household survey in Puerto Rico: comparison of survey responses of cocaine and heroin use with hair tests. Int J Epidemiol. 2001;30:1042–1049.
   PubMed Web of Science ®Google Scholar
• Fendrich M, Johnson T, Wislar JS, Sudman S. The feasibility of hair testing in a household survey of drug abuse. In: Mieczkowski T, ed. Drug Testing Technology: Assessment of Field Applications. Boca Raton, FL: CRC Press; 1999.
   Google Scholar
• MacKellar DA, Gallagher KM, Finlayson T, Sanchez T, Lansky A, Sullivan PS. Surveillance of HIV risk and prevention behaviors of men who have sex with men–a national application of venue-based, time-space sampling. Public Health Rep. 2007;122:39–47.
   PubMed Web of Science ®Google Scholar
• George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104:e16–e31.
   PubMed Web of Science ®Google Scholar
• Coetzee B, Kagee A, Tomlinson M, Warnich L, Ikediobi O. Reactions, beliefs and concerns associated with providing hair specimens for medical research among a South African sample: a qualitative approach. Future Virol. 2012;7:1135–1142.
   PubMed Web of Science ®Google Scholar
• Ridpath A, Driver CR, Nolan ML, et al. Illnesses and deaths among persons attending an electronic dance-music festival – New York City, 2013. MMWR Morb Mortal Wkly Rep 2014;63:1195–1198.
   PubMed Web of Science ®Google Scholar
• Lund A, Turris SA. Mass-gathering medicine: risks and patient presentations at a 2-day electronic dance music event. Prehosp Disaster Med. 2015;30:271–278.
   PubMed Web of Science ®Google Scholar
• Barratt MJ, Bruno R, Ezard N, Ritter A. Pill testing or drug checking in Australia: acceptability of service design features. Drug Alcohol Rev. 2018;37:226–236.
   PubMed Web of Science ®Google Scholar
• Fendrich M, Kim JYS. The experience and acceptability of drug testing: poll trends. J Drug Issues. 2002;32:81–95.
   Web of Science ®Google Scholar